We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.08%
5 Year Est. Return
+53.42%
10 Year Est. Return
AUM
$1.58B
AUM Growth
+$26.6M
Cap. Flow
-$50.9M
Cap. Flow %
-3.23%
Top 10 Hldgs %
25.87%
Holding
640
New
83
Increased
185
Reduced
280
Closed
78

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.4M
2
SBUX icon
Starbucks
SBUX
+$6.99M
3
DIS icon
Walt Disney
DIS
+$5.32M
4
BA icon
Boeing
BA
+$4.93M
5
CAT icon
Caterpillar
CAT
+$4.92M

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$16M
2
GE icon
GE Aerospace
GE
+$13.5M
3
RTX icon
RTX Corp
RTX
+$5.63M
4
NKE icon
Nike
NKE
+$4.69M
5
CB icon
Chubb
CB
+$4.22M

Sector Composition

Rank Sector Weight
1 Technology 16.32%
2 Healthcare 16.14%
3 Financials 15.68%
4 Industrials 10.69%
5 Consumer Discretionary 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
26
Biogen
BIIB
$30B
$16.4M 1.04%
51,535
-1,435
-3% -$460K
JNJ icon
27
Johnson & Johnson
JNJ
$618B
$16.3M 1.04%
116,839
-7,460
-6% -$1.04M
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.1T
$13.8M 0.88%
69,734
-7,200
-9% -$1.37M
HD icon
29
Home Depot
HD
$331B
$13.5M 0.86%
71,341
+2,540
+4% +$438K
XOM icon
30
ExxonMobil
XOM
$644B
$12.9M 0.82%
153,709
-12,900
-8% -$1.07M
WFC icon
31
Wells Fargo
WFC
$261B
$12.8M 0.82%
211,678
-3,100
-1% -$175K
BAC icon
32
Bank of America
BAC
$435B
$10.4M 0.66%
351,295
-80,450
-19% -$2.22M
UNH icon
33
UnitedHealth
UNH
$376B
$10.3M 0.66%
46,855
+4,305
+10% +$912K
MO icon
34
Altria Group
MO
$114B
$9.27M 0.59%
129,826
+990
+0.8% +$66.3K
VZ icon
35
Verizon
VZ
$195B
$9.19M 0.58%
173,637
-57,380
-25% -$2.82M
MCD icon
36
McDonald's
MCD
$192B
$8.84M 0.56%
51,361
-8,205
-14% -$1.38M
BA icon
37
Boeing
BA
$171B
$8.8M 0.56%
29,828
+18,210
+157% +$4.93M
CSCO icon
38
Cisco
CSCO
$457B
$8.76M 0.56%
228,757
-43,350
-16% -$1.55M
T icon
39
AT&T
T
$159B
$8.66M 0.55%
294,961
-30,319
-9% -$828K
UNP icon
40
Union Pacific
UNP
$174B
$8.17M 0.52%
60,925
+90
+0.1% +$10.9K
C icon
41
Citigroup
C
$222B
$7.97M 0.51%
107,080
-16,250
-13% -$1.2M
PM icon
42
Philip Morris
PM
$297B
$7.95M 0.5%
75,251
-3,155
-4% -$336K
NVDA icon
43
NVIDIA
NVDA
$4.86T
$7.83M 0.5%
1,619,400
+230,400
+17% +$1.14M
AVGO icon
44
Broadcom
AVGO
$1.85T
$7.57M 0.48%
294,800
+37,050
+14% +$963K
ABBV icon
45
AbbVie
ABBV
$443B
$7.47M 0.47%
77,257
+49,300
+176% +$4.65M
ORCL icon
46
Oracle
ORCL
$374B
$7.33M 0.47%
154,945
+44,690
+41% +$2.19M
PFE icon
47
Pfizer
PFE
$143B
$7.26M 0.46%
211,351
-87,219
-29% -$2.97M
MA icon
48
Mastercard
MA
$506B
$7.24M 0.46%
47,805
+6,525
+16% +$970K
GE icon
49
GE Aerospace
GE
$374B
$7.16M 0.45%
85,605
-141,282
-62% -$13.5M
DD icon
50
DuPont de Nemours
DD
$18.5B
$7.03M 0.45%
38,996
-2,780
-7% -$501K

Similar funds

Oakbrook Investments's Q4 2017 Portfolio in Review

As of Q4 2017, Oakbrook Investments held 640 positions worth $1.58B, up 1.7% from $1.55B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Oakbrook Investments withdrew a net $50.9M in Q4 2017, closing 78 positions and reducing 280 holdings. Its most notable exit was Stericycle Inc, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oakbrook Investments opened a new position in Eli Lilly worth $3.71M.

  • Oakbrook Investments's largest Q4 2017 buy was Eli Lilly: 43,950 shares worth $3.71M.
  • Oakbrook Investments added most to Apple in Q4 2017, an estimated $14.4M increase.
  • Oakbrook Investments's biggest Q4 2017 reduction was GE Aerospace, cutting an estimated $13.5M.
  • Oakbrook Investments fully exited Stericycle Inc in Q4 2017, selling an estimated $16M.
  • Oakbrook Investments's ten largest holdings make up 26% of its $1.58B portfolio in Q4 2017.
  • Oakbrook Investments opened 83 new positions and closed 78 in Q4 2017.
  • Oakbrook Investments's portfolio value rose 1.7% quarter-over-quarter to $1.58B.

Based on Oakbrook Investments's 13F filing for Q4 2017, filed 18 Jan 2018.